Skip to Main Content

Paper Details

Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.
Clin Transl Sci
22
2010
Cardiac, HF, Hyponatremia, Lixivaptan, Patient, Patients, aquaresis, cardiac, cognitive dysfunction, dyspnea, electrolyte, electrolyte disorder, heart failure, hypokalemia, hyponatremia, lixivaptan, patient, patients, renal dysfunction, sodium, vasopressin, vasopressin V, vasopressin V(2) -receptor
Author NameAffiliation
William T AbrahamThe Ohio State University Heart Center
  • 1 - 1

Datasets

Release 1.2